<DOC>
	<DOCNO>NCT00855114</DOCNO>
	<brief_summary>RATIONALE : Everolimus may stop growth tumor cell block enzymes need cell growth block blood flow tumor . PURPOSE : This phase II trial study well everolimus work treat woman breast cancer remove surgery .</brief_summary>
	<brief_title>Everolimus Treating Women With Breast Cancer That Can Be Removed Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether administration everolimus result decrease total choline , surrogate marker response , least 30 % woman resectable breast cancer . Secondary - Determine whether tumor activate mTOR signaling , measure phosphorylation 4E-BP1 activity cap dependent translational complex , identify woman responsive everolimus . OUTLINE : Patients receive oral everolimus daily day 1-7 absence disease progression unacceptable toxicity . Within 24 hour complete everolimus , patient undergo surgery . Tumor tissue sample collect baseline surgery analysis mTOR target ( i.e. , 4E-BP1 , p70S6 kinase phosphorylation ) , Ki67 , cleave caspase 3 , activity cap dependent translational complex immunohistochemical assay . Patients also undergo MRI/MRS everolimus therapy total choline glucose level measurement . After completion study therapy , patient follow 30 day .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>Diagnosis invasive breast cancer Resectable disease Measurable disease , define primary breast mass &gt; 2.0 cm breast image clinical exam Planning undergo surgical resection neoadjuvant therapy Menopausal status specify Eastern Clinical Oncology Group ( ECOG ) performance status 01 Absolute neutrophil count ( ANC ) ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3 Hemoglobin &gt; 9.0 g/dL Aspartate aminotransferase/alanine aminotransferase ( AST/ALT ) ≤ 2.5 time upper limit normal ( ULN ) Creatinine ≤ 1.5 time ULN Total bilirubin ≤ 1.5 time ULN Not pregnant Negative pregnancy test Fertile patient must use effective contraception Intracranial disease Hormone receptor status specify Obese ( &gt; 250 pound ) Immunosuppression cause ( e.g. , know HIV infection ) History severe asthma and/or allergy History severe claustrophobia Ferromagnetic implant , history shotgun wound and/or shrapnel , cardiac pacemaker , similar situation would contrary strong magnetic force Bleeding diathesis Unstable systemic disease , include limited , follow : Uncontrolled diabetes Severe infection Severe malnutrition Uncontrolled hypertension Unstable angina Ventricular arrhythmias Active ischemic heart disease Congestive heart failure Myocardial infarction within past 6 month Chronic liver disease Renal disease Active upper gastrointestinal tract ulceration Less 4 week since prior investigational drug Prior therapy sirolimus analogue Concurrent immunosuppressive therapy ( e.g. , steroid , cytotoxic agent , concurrent radiotherapy ) Concurrent anticoagulation ( i.e. , coumadin )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>stage II breast cancer</keyword>
	<keyword>stage III breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
</DOC>